Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Giuffre Randall Michael
Director at DiaMedica Therapeutics. Filing since 11 Dec 2018.
CIK 0001759822
Company
Date
Role
Action
Shares
Amount
Of holding
DMAC
DiaMedica Therapeutics Inc.
23 Jun 2023
Director
Bought
65,000
$254.15K
22.0%
DMAC
DiaMedica Therapeutics Inc.
9 Dec 2022
Director
Bought
37,079
$53.02K
16.6%
DMAC
DiaMedica Therapeutics Inc.
8 Dec 2022
Director
Bought
20,000
$28.00K
9.8%
DMAC
DiaMedica Therapeutics Inc.
7 Dec 2022
Director
Bought
22,574
$31.60K
12.5%
DMAC
DiaMedica Therapeutics Inc.
6 Dec 2022
Director
Bought
2,300
$3.11K
1.3%
DMAC
DiaMedica Therapeutics Inc.
1 Dec 2022
Director
Bought
46,952
$56.33K
35.8%
DMAC
DiaMedica Therapeutics Inc.
30 Nov 2022
Director
Bought
2,970
$3.53K
2.3%
DMAC
DiaMedica Therapeutics Inc.
29 Nov 2022
Director
Bought
18,125
$21.57K
16.4%
DMAC
DiaMedica Therapeutics Inc.
20 Nov 2020
Director
Bought
15,000
$63.91K
16.0%
DMAC
DiaMedica Therapeutics Inc.
11 Dec 2018
Director
Bought
11,250
$45.00K
15.1%
10 decisions on file.